The Rivkin Center Has Joined OCRA
The Rivkin Center Has Joined OCRA
This historic collaboration unites two respected organizations committed to advancing research for better treatments and a cure for ovarian cancer.
Expanding Research Through Partnership
Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research has combined with OCRA.
Please explore the resources below to learn more about the support and tools available from OCRA.
Support & Resources
Research
Center for Public Policy
Get Involved
OCRA Rivkin Family SummeRun
Join thousands of participants of all ages and fitness levels at Seattle’s Seward Park to raise awareness and fund critical research for ovarian cancer. Registration opens in early April.
About
Related Topics
The Overview: August 2026
September is Ovarian and Gynecologic Cancer Awareness Month—a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. This year, that push forward took a major step. In May, we launched the Research Exchange, a new kind of online community that represents a fundamental shift in how … Continued
OCRA’s Ovarian Cycle Rio Grande Valley Gears Up for Year 11 (KRGV-TV)
Ovarian Cycle is back in Rio Grande Valley on September 19, and KRGV-TV Channel 5 News (ABC) recently sat down with Marlynn Olivarez, organizer of the fundraiser, to talk about the event and why it matters. Over the past 10 years, the Rio Grande Valley community has raised more than $66,000 for ovarian and gynecologic cancer research … Continued
The FDA Wants to Hear From You at OCRA’s Online Conference
Submit Your Questions for the FDA Listening Session On September 16–17, Ovarian Cancer Research Alliance (OCRA) will host the International Gynecologic Cancer Conference®, the largest conference dedicated to the gynecologic cancer community. Day 2 features a special opportunity: a Listening Session with leaders from the U.S. Food and Drug Administration (FDA). Ask questions about the FDA’s … Continued